Flourtown, PA, United States of America

Richard L Skelly

This inventor holds 14 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard L Skelly. Retrieved from https://idiyas.com/inventor/richard-l-skelly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Mind of Richard L. Skelly: Revolutionizing Statin Accessibility

Introduction

Richard L. Skelly, based in Flourtown, PA, is an accomplished inventor with an impressive portfolio of 12 patents. His work focuses significantly on improving healthcare accessibility, specifically through innovations related to medication dispensing. Skelly's latest patents reflect his commitment to revolutionizing the way statin medications are accessible to patients in need.

Latest Patents

Among Richard Skelly's latest innovations is the patent for "Systems and Methods for Dispensing a Statin Medication Over the Counter." This groundbreaking method facilitates the treatment of atherosclerotic cardiovascular disease by enabling qualified subjects to access statin pharmaceutical compositions without a prescription. These compositions can include well-known active ingredients such as atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, or simvastatin.

Also noteworthy is another patent under the same title, which outlines a comprehensive system for over-the-counter statin delivery. The innovation incorporates filtering mechanisms using survey results from patients to determine their qualification for safe medication access. This process ensures that patients receive adequate warnings based on their health assessments and confirms their understanding before medication provision.

Career Highlights

Richard L. Skelly contributes his talents to AstraZeneca UK Limited, a leading global biopharmaceutical company known for its focus on innovative medicines. His role at AstraZeneca allows him to work on projects that bridge the gap between pharmaceutical innovation and patient care, enhancing the overall delivery of healthcare solutions.

Collaborations

Skelly's journey in innovation is complemented by his collaborations with talented colleagues, including Judy Firor and James Blasetto. Together, they share insights and expertise to refine their approaches to pharmaceutical challenges, fostering a team environment that encourages groundbreaking advancements in the industry.

Conclusion

In summary, Richard L. Skelly stands out as a significant contributor to the field of healthcare innovation, particularly through his patents aimed at making statin medications more accessible. His work not only reflects his dedication to patient care but also marks a pivotal advancement in how pharmacies can serve their customers effectively and safely. Through his career at AstraZeneca and his innovative collaborations, Skelly continues to impact the medical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…